Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer
Year: 2020
Type: article
Source: Cancer Immunology Immunotherapy
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G2057460781, G3458082858, G7646955266
OpenAlex ID: W3037726457
